TherapeuticsMD (TXMD) Total Current Liabilities (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Total Current Liabilities came in at $4.9 million in Q1 2026, up 3.59% YoY from $4.7 million in Q1 2025, and up 2.63% on a QoQ basis from $4.8 million in Q4 2025.
TherapeuticsMD (TXMD) Total Current Liabilities (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 17 years of Total Current Liabilities data on file, last reported at $4.9 million in Q1 2026.
- Quarterly Total Current Liabilities rose 3.59% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (up 3.59% YoY) and the FY2025 annual result came in at $4.8 million, down 7.38% from the prior year.
- Total Current Liabilities advanced to $4.9 million in Q1 2026, from $4.8 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $264.8 million in Q1 2022 to a low of $4.7 million in Q2 2025.
- A 5-year average of $44.3 million and a median of $6.5 million in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities surged 332.14% — and 2023, when it slumped 92.7%.
- Tracing TXMD's Total Current Liabilities over 5 years: stood at $46.8 million in 2022, then tumbled by 85.37% to $6.9 million in 2023, then decreased by 24.63% to $5.2 million in 2024, then declined by 7.38% to $4.8 million in 2025, then gained by 2.63% to $4.9 million in 2026.
- The last three Total Current Liabilities figures came in at $4.9 million (Q1 2026), $4.8 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.49 Bn | 43.53 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 43.69 Bn | 40.04 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 32.30 Bn | 30.62 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 21.97 Bn | 19.31 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.97 Bn | 18.08 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 1.79 Bn |
| 10 | TherapeuticsMD | 23.96 Mn | 14.77 Mn | - | 5.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.00 Mn |
| Mar 31, 2026 | 4.91 Mn |
| Dec 31, 2025 | 4.79 Mn |
| Sep 30, 2025 | 4.95 Mn |
| Jun 30, 2025 | 4.66 Mn |
| Mar 31, 2025 | 4.74 Mn |
| Dec 31, 2024 | 5.17 Mn |
| Sep 30, 2024 | 5.98 Mn |
| Jun 30, 2024 | 5.82 Mn |
| Mar 31, 2024 | 6.47 Mn |
| Dec 31, 2023 | 6.85 Mn |
| Sep 30, 2023 | 14.51 Mn |
| Jun 30, 2023 | 14.36 Mn |
| Mar 31, 2023 | 19.34 Mn |
| Dec 31, 2022 | 46.84 Mn |
| Sep 30, 2022 | 174.07 Mn |
| Jun 30, 2022 | 163.99 Mn |
| Mar 31, 2022 | 264.84 Mn |
| Dec 31, 2021 | 252.89 Mn |
| Sep 30, 2021 | 86.27 Mn |